非肽类缓激肽B2受体拮抗剂FR165649和激动剂FR190997的药理学特性

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

作者信息

Asano M, Hatori C, Sawai H, Johki S, Inamura N, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Mizutani T, Oku T, Nakahara K

机构信息

Department of Pharmacology, Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.

出版信息

Br J Pharmacol. 1998 Jun;124(3):441-6. doi: 10.1038/sj.bjp.0701813.

DOI:10.1038/sj.bjp.0701813

PMID:9647466

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1565402/

Abstract

The nonpeptide bradykinin (BK) B2 receptor antagonist, FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl ]-N-methylamino]benzyloxy]-2-methylquinoline), and agonist, FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl) cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridyl methoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2-pyridylmethoxy group is the only structural difference between them. 2. Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea-pig ileum membranes, with an IC50 of 4.7 x 10(-10) M and 1.5 x 10(-9) M, respectively. They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 x 10(-9) M and 9.8 x 10(-10) M, respectively. 3. In guinea-pig isolated ileum-preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration-response curves to BK on contraction. Analysis of the data produced a nominal pA2 value of 9.2+/-0.1 (n=5) and a slope of 1.4+/-0.1 (n=5). On the other hand, FR190997 induced concentration-dependent contraction of guinea-pig ilea with a pD2 of 7.9+/-0.2 and the contraction was inhibited by a specific peptide bradykinin B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]BK) in a non-competitive manner. 4. In IMR-90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10(-7) M) of the concentration-response curves to BK on PI hydrolysis. FR190997 induced concentration-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4+/-0.1, and this effect was inhibited by Hoe 140. 5. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.

摘要

非肽类缓激肽（BK）B2受体拮抗剂FR165649（8 - [2,6 - 二氯 - 3 - [N - [(E) - 4 - (N - 甲基氨基甲酰基)肉桂酰胺基乙酰基] - N - 甲基氨基]苄氧基] - 2 - 甲基喹啉）和激动剂FR190997（8 - [2,6 - 二氯 - 3 - [N - [(E) - 4 - (N - 甲基氨基甲酰基)肉桂酰胺基乙酰基] - N - 甲基氨基]苄氧基] - 2 - 甲基 - 4 - (2 - 吡啶甲氧基)喹啉）已被鉴定出来。这些化合物具有共同的化学结构，2 - 吡啶甲氧基是它们之间唯一的结构差异。
FR165649和FR190997均可取代豚鼠回肠膜中[³H] - BK与B2受体的结合，IC50分别为4.7×10⁻¹⁰ M和1.5×10⁻⁹ M。它们还可取代人肺成纤维细胞IMR - 90中[³H] - BK与B2受体的结合，IC50分别为1.6×10⁻⁹ M和9.8×10⁻¹⁰ M。
在豚鼠离体回肠制备物中，FR165649对收缩无激动作用，且使收缩时BK的浓度 - 反应曲线平行右移。数据分析得出名义pA2值为9.2±0.1（n = 5），斜率为1.4±0.1（n = 5）。另一方面，FR190997诱导豚鼠回肠浓度依赖性收缩，pD2为7.9±0.2，且该收缩被特异性肽缓激肽B2受体拮抗剂Hoe 140（D - Arg - [Hyp3, Thi5, D - Tic7, Oic8]BK）以非竞争性方式抑制。
在IMR - 90细胞中，FR165649对磷脂酰肌醇（PI）水解无激动作用，且使PI水解时BK的浓度 - 反应曲线平行右移（在10⁻⁷ M时约为200倍的位移）。FR190997在IMR - 90细胞中诱导浓度依赖性PI水解，pD2为8.4±0.1，且该作用被Hoe 140抑制。
这些结果表明，FR165649和FR190997分别是强效的缓激肽B2受体拮抗剂和激动剂，且激动活性取决于非肽配体的一小部分。FR165649和FR190997可能是研究配体与受体之间关系的有用工具。

相似文献

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

Br J Pharmacol. 1998 Jun;124(3):441-6. doi: 10.1038/sj.bjp.0701813.

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.

Br J Pharmacol. 1997 Feb;120(4):617-24. doi: 10.1038/sj.bjp.0700955.

Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.

Br J Pharmacol. 1997 Jun;121(3):469-76. doi: 10.1038/sj.bjp.0701159.

Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.

Eur J Pharmacol. 2000 Dec 8;409(2):185-94. doi: 10.1016/s0014-2999(00)00850-5.

Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.

Can J Physiol Pharmacol. 1997 Jun;75(6):622-8.

The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.

Eur J Pharmacol. 2004 May 3;491(2-3):121-5. doi: 10.1016/j.ejphar.2004.03.031.

Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.

Br J Pharmacol. 2001 Aug;133(8):1296-306. doi: 10.1038/sj.bjp.0704208.

Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.

Br J Pharmacol. 1994 Oct;113(2):607-13. doi: 10.1111/j.1476-5381.1994.tb17033.x.

Characterization of bradykinin receptors in guinea pig gall bladder.

J Pharmacol Exp Ther. 1993 Sep;266(3):1291-9.

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.

Mol Pharmacol. 1997 Jul;52(1):16-20. doi: 10.1124/mol.52.1.16.

引用本文的文献

Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

ACS Pharmacol Transl Sci. 2020 Nov 5;3(6):1391-1421. doi: 10.1021/acsptsci.0c00137. eCollection 2020 Dec 11.

Hypothesized and found mechanisms for potentiation of bradykinin actions.

Signal Transduct. 2006 Feb;6(1):5-18. doi: 10.1002/sita.200500061. Epub 2006 Jan 17.

Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.

J Pharmacol Exp Ther. 2013 Oct;347(1):100-16. doi: 10.1124/jpet.113.206896. Epub 2013 Jul 26.

Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha.

Peptides. 2005 Jul;26(7):1235-47. doi: 10.1016/j.peptides.2005.03.046. Epub 2005 Apr 25.

Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.

Br J Pharmacol. 2001 Aug;133(8):1296-306. doi: 10.1038/sj.bjp.0704208.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

非肽类缓激肽B2受体拮抗剂FR165649和激动剂FR190997的药理学特性

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

作者信息

Asano M, Hatori C, Sawai H, Johki S, Inamura N, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Mizutani T, Oku T, Nakahara K

机构信息

Department of Pharmacology, Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.

出版信息

Br J Pharmacol. 1998 Jun;124(3):441-6. doi: 10.1038/sj.bjp.0701813.

DOI:10.1038/sj.bjp.0701813

PMID:9647466

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1565402/

Abstract

The nonpeptide bradykinin (BK) B2 receptor antagonist, FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl ]-N-methylamino]benzyloxy]-2-methylquinoline), and agonist, FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl) cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridyl methoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2-pyridylmethoxy group is the only structural difference between them. 2. Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea-pig ileum membranes, with an IC50 of 4.7 x 10(-10) M and 1.5 x 10(-9) M, respectively. They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 x 10(-9) M and 9.8 x 10(-10) M, respectively. 3. In guinea-pig isolated ileum-preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration-response curves to BK on contraction. Analysis of the data produced a nominal pA2 value of 9.2+/-0.1 (n=5) and a slope of 1.4+/-0.1 (n=5). On the other hand, FR190997 induced concentration-dependent contraction of guinea-pig ilea with a pD2 of 7.9+/-0.2 and the contraction was inhibited by a specific peptide bradykinin B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]BK) in a non-competitive manner. 4. In IMR-90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10(-7) M) of the concentration-response curves to BK on PI hydrolysis. FR190997 induced concentration-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4+/-0.1, and this effect was inhibited by Hoe 140. 5. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.

摘要

非肽类缓激肽（BK）B2受体拮抗剂FR165649（8 - [2,6 - 二氯 - 3 - [N - [(E) - 4 - (N - 甲基氨基甲酰基)肉桂酰胺基乙酰基] - N - 甲基氨基]苄氧基] - 2 - 甲基喹啉）和激动剂FR190997（8 - [2,6 - 二氯 - 3 - [N - [(E) - 4 - (N - 甲基氨基甲酰基)肉桂酰胺基乙酰基] - N - 甲基氨基]苄氧基] - 2 - 甲基 - 4 - (2 - 吡啶甲氧基)喹啉）已被鉴定出来。这些化合物具有共同的化学结构，2 - 吡啶甲氧基是它们之间唯一的结构差异。
FR165649和FR190997均可取代豚鼠回肠膜中[³H] - BK与B2受体的结合，IC50分别为4.7×10⁻¹⁰ M和1.5×10⁻⁹ M。它们还可取代人肺成纤维细胞IMR - 90中[³H] - BK与B2受体的结合，IC50分别为1.6×10⁻⁹ M和9.8×10⁻¹⁰ M。
在豚鼠离体回肠制备物中，FR165649对收缩无激动作用，且使收缩时BK的浓度 - 反应曲线平行右移。数据分析得出名义pA2值为9.2±0.1（n = 5），斜率为1.4±0.1（n = 5）。另一方面，FR190997诱导豚鼠回肠浓度依赖性收缩，pD2为7.9±0.2，且该收缩被特异性肽缓激肽B2受体拮抗剂Hoe 140（D - Arg - [Hyp3, Thi5, D - Tic7, Oic8]BK）以非竞争性方式抑制。
在IMR - 90细胞中，FR165649对磷脂酰肌醇（PI）水解无激动作用，且使PI水解时BK的浓度 - 反应曲线平行右移（在10⁻⁷ M时约为200倍的位移）。FR190997在IMR - 90细胞中诱导浓度依赖性PI水解，pD2为8.4±0.1，且该作用被Hoe 140抑制。
这些结果表明，FR165649和FR190997分别是强效的缓激肽B2受体拮抗剂和激动剂，且激动活性取决于非肽配体的一小部分。FR165649和FR190997可能是研究配体与受体之间关系的有用工具。

非肽类缓激肽B2受体拮抗剂FR165649和激动剂FR190997的药理学特性

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

非肽类缓激肽B2受体拮抗剂FR165649和激动剂FR190997的药理学特性

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

作者信息

机构信息

出版信息